HTFL · XBRL financial data
Heartflow financial statements, every fiscal year
The same tables from 1 filing, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (HTFL's year ends in late December)
| In millions of dollars | Dec 31, 2025 |
|---|---|
| Revenue from contracts with customers | 176 |
| Cost of revenue | 41 |
| Gross profit | 135 |
| Research and development | 65 |
| Selling, general and administrative | 134 |
| General and administrative | 39 |
| Total operating expenses | 199 |
| Operating income (loss) | (64) |
| Interest income | 6 |
| Interest expense | 15 |
| Other income (expense) | (0) |
| Income tax expense (benefit) | (0) |
| Net income (loss) | (117) |
| Earnings per share, basic USD per share | (3.17) |
| Earnings per share, diluted USD per share | (3.17) |
| Weighted average shares, basic millions of shares | 37 |
| Weighted average shares, diluted millions of shares | 37 |
Balance sheet
CSVFiscal years (HTFL's year ends in late December)
| In millions of dollars | Dec 31, 2025 |
|---|---|
| Cash and cash equivalents | 45 |
| Short-term investments | 132 |
| Accounts receivable | 29 |
| Prepaid and other current assets | 14 |
| Total current assets | 220 |
| Property and equipment, net | 9 |
| Right-of-use asset | 17 |
| Total assets | 359 |
| Accounts payable | 3 |
| Total current liabilities | 42 |
| Lease liability, non-current | 16 |
| Total liabilities | 59 |
| Accumulated deficit | (1,088) |
| Total stockholders' equity | 301 |
| Total liabilities and equity | 359 |
| Common shares outstanding (cover page) millions of shares | 86 |
Cash flows
CSVFiscal years (HTFL's year ends in late December)
| In millions of dollars | Dec 31, 2025 |
|---|---|
| Net income (loss) | (117) |
| Stock-based compensation | 14 |
| Depreciation and amortization | 5 |
| Net cash from operating activities | (54) |
| Purchases of property and equipment | 5 |
| Net cash from investing activities | (239) |
| Repayments of long-term debt | 115 |
| Net cash from financing activities | 286 |
| Net change in cash | (6) |
Compare with peers
SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Heartflow | 34 | 64 | (8.6)* | 87.0M | 19.0 quarters | 10-QJun 30, 2026 |
| Mimedx Group | 121 | 62 | 3.9* | 145.9M | — | 10-QSep 30, 2026 |
| Establishment Labs Holdings | 71 | 68 | (17)* | 29.8M | 4.3 quarters | 10-QJun 30, 2026 |
| Lemaitre Vascular | 27 | not reported | 16* | 22.9M | — | 10-QJun 30, 2026 |
| Cerus | 16 | 58 | 3* | 202.0M | — | 10-QSep 30, 2026 |
| SkinHealth Systems | 206 | 72 | 2.7* | 130.1M | — | 10-QJun 30, 2026 |
| Orthopediatrics | 17 | 73 | 4.5* | 26.1M | — | 10-QSep 30, 2026 |
| SI-BONE | 35 | 56 | 5.9* | 45.1M | — | 10-QSep 30, 2026 |
| Axogen | 329 | 76 | 17* | 59.7M | — | 10-QSep 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.